Iterum Therapeutics plc
ITRM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $34,867 | $25,535 | $10,279 | $64,039 |
| - Cash | $24,125 | $6,071 | $21,092 | $27,446 |
| + Debt | $45,534 | $18,956 | $30,102 | $30,425 |
| Enterprise Value | $56,276 | $38,420 | $19,289 | $67,018 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$254 | -$1,750 | -$1,800 | -$2,104 |
| % Margin | – | – | – | – |
| EBITDA | -$21,728 | -$34,580 | -$39,972 | -$83,202 |
| % Margin | – | – | – | – |
| Net Income | -$24,774 | -$38,371 | -$44,434 | -$91,564 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.26 | -2.96 | -3.63 | -8.41 |
| % Growth | 57.4% | 18.5% | 56.8% | – |
| Operating Cash Flow | -$26,770 | -$39,330 | -$18,473 | -$15,842 |
| Capital Expenditures | -$2 | -$13 | -$62 | -$61 |
| Free Cash Flow | -$26,772 | -$39,343 | -$18,535 | -$15,903 |